Ipilimumab with and without Nivolumab in Patients with Classic Hodgkin Lymphoma with Progression after PD-1 Blockade

Authors
Category Primary study
JournalBlood
Year 2024
This article has no abstract
Epistemonikos ID: 7e34d523e0fdd8ecf6915839a2332a72a86fbb75
First added on: Jul 12, 2025